Minimal change disease: Difference between revisions
No edit summary |
|||
(9 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information, click [[Minimal change disease (patient information)|here]]''' | '''For patient information, click [[Minimal change disease (patient information)|here]]''' | ||
{{Minimal change disease}} | {{Minimal change disease}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{CZ}}, [[User:YazanDaaboul|Yazan Daaboul]], [[User:Sergekorjian|Serge Korjian]] {{HK}} ;{{VKG}} | ||
{{SK}} Lipoid nephrosis, nil, nothing-in-light microscopy, steroid-responsive nephrotic syndrome, steroid-sensitive nephrotic syndrome | |||
==[[Minimal change disease overview|Overview]]== | ==[[Minimal change disease overview|Overview]]== | ||
Line 36: | Line 23: | ||
==[[Minimal change disease risk factors|Risk Factors]]== | ==[[Minimal change disease risk factors|Risk Factors]]== | ||
==[[Minimal change disease natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Minimal change disease natural history, complications and prognosis|Natural History, Complications, and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Minimal change disease history and symptoms|History and Symptoms]] | [[Minimal change disease physical examination|Physical Examination]] | [[Minimal change disease laboratory findings|Laboratory Findings]] | [[Minimal change disease immunohistology|Immunohistology]] | [[Minimal change disease electron microscopy|Electron Microscopy]] | [[Minimal change disease other imaging findings|Other Imaging Findings | [[Minimal change disease history and symptoms|History and Symptoms]] | [[Minimal change disease physical examination|Physical Examination]] | [[Minimal change disease laboratory findings|Laboratory Findings]] | [[Minimal change disease immunohistology|Immunohistology]] | [[Minimal change disease electron microscopy|Electron Microscopy]] | [[Minimal change disease other imaging findings|Other Imaging Findings]] | ||
==Treatment== | ==Treatment== | ||
[[Minimal change disease medical therapy|Medical Therapy | [[Minimal change disease medical therapy|Medical Therapy]] | [[Minimal change disease primary prevention|Primary Prevention]] | [[Minimal change disease secondary prevention|Secondary Prevention]] | [[Minimal change disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Minimal change disease future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Line 48: | Line 35: | ||
[[Minimal change disease case study one|Case #1]] | [[Minimal change disease case study one|Case #1]] | ||
{{Nephrology}} | |||
{{ | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | |||
[[Category: | [[Category:Nephrology]] | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] | ||
[[Category:Urology]] | [[Category:Urology]] | ||
Latest revision as of 17:17, 7 May 2018
For patient information, click here
Minimal Change Disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Minimal change disease On the Web |
American Roentgen Ray Society Images of Minimal change disease |
Risk calculators and risk factors for Minimal change disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Yazan Daaboul, Serge Korjian Syed Hassan A. Kazmi BSc, MD [3] ;Vamsikrishna Gunnam M.B.B.S [4]
Synonyms and keywords: Lipoid nephrosis, nil, nothing-in-light microscopy, steroid-responsive nephrotic syndrome, steroid-sensitive nephrotic syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Minimal change disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Immunohistology | Electron Microscopy | Other Imaging Findings
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies